1.Huang X# , Yan J#, Zhang M# , Wang Y#, Chen Y, Fu X, Wei R, Zheng X, Liu Zh, Zhang X; Yang H,Hao B, Shen Y, Su Y, Cong X, Huang M, Tan M*, Ding J*, Geng M*.Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-aberrant Solid Tumors, Cell, 2018;175(1):186-199.
2.Zeng H#, Qu J#, Jin N#, Xu J, Lin C, Yang X, He X, Tang S, Lan X, Yang X, Chen Z, Huang M*, Ding J*, Geng M*.Feedback activation of leukemia inhibitory factor receptor limits response to histone deacetylases inhibitors in breast cancer. Cancer Cell, 2016;30(3):459-73.
3.Lian Q#, Xu J#, Yan S, Huang M*, Ding H, Sun X, Ding J*, Sun B* and Geng M*. Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation. Cell Res. 2017;27(6):784-800.
4.Zhang T#, Qu R#, Chan Sh#, Lai M, Tong L, Feng F, Chen H, Song T, Peiran Song, Gang Bai, Yingqiang Liu, Yanan Wang, Yan Li, Yi Su, Shen Y, Sun Y, Chen Y, Geng M, Ding K*, Ding J*, Xie H*.Discovery of a Novel Third-Generation EGFR Inhibitor and Identification of a Potential Combination Strategy to Overcome Resistance. Mol Cancer. 2020;19(1):90.
5.Wang X#, Zhang M, Ping F, Liu H, Sun J, Wang Y, Shen A, Ding J*, Geng M*. Identification and therapeutic intervention of coactivated anaplastic lymphoma kinase, fibroblast growth factor receptor 2, and ephrin type‐A receptor 5 kinases in hepatocellular carcinoma. Hepatology. 2019;69(2):573-586.
6.Yue X#, Ai J#, Xu Y#, Chen Y#, Huang M, Yang X, Hu B, Zhang H, He Ch, Yang X, Tang W, Peng X, Dong L, Wang H, Fan J*, Ding J*, Geng M*. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. Hepatology. 2017;65(6):1948-1962.
7.Xie Q, Chi Sh, Fang Y, Sun Y, Meng L, Ding J *, Chen Y*. PI3K inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma. Sig Transduct Target Ther. 2021;6(1):130.
8.Chen Y#, Wang Y#, Zhang J, Su Y, Shen Y, Jiang D, Hou Y , Geng M*, and Ding J*. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin . Nature Commun. 2017; 8(1):27.
9.Dai X#, Yan J#, Fu X, Pan Q, Sun D, Xu Y, Wang J, Nie L, Tong L, Shen A, Zheng M, Huang M, Tan M, Liu H, Huang X*, Ding J*, Geng M*. Aspirin inhibits cancer metastasis and angiogenesis via targeting heparanase. Clin Cancer Res. 2017;23(20):6267-6278.
10.Liu H#, Ai J#, Shen A, Chen Y, Wang X, Peng X, Chen H, Shen Y, Huang M*, Ding J*, Geng M*.c-Myc alteration determines the therapeutic response to FGFR inhibitors. Clin Cancer Res. 2017; 23(4):974-984.